BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 25020177)

  • 1. [The morphological features of the uterine body adenocarcinoma].
    Dzhaparidze NA; Chakvetatdze LB; Dzhikia ID
    Georgian Med News; 2014 Jun; (231):72-7. PubMed ID: 25020177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Papillary-serous adenocarcinoma of the uterine cervix during tamoxifen therapy after bilateral breast cancer.
    Watrowski R; Striepecke E; Jäger C; Bauknecht T; Horst C
    Anticancer Res; 2012 Nov; 32(11):5075-8. PubMed ID: 23155282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Markers of proliferative activity are predictors of patient outcome for low-grade endometrioid adenocarcinoma but not papillary serous carcinoma of endometrium.
    Al Kushi A; Lim P; Aquino-Parsons C; Gilks CB
    Mod Pathol; 2002 Apr; 15(4):365-71. PubMed ID: 11950909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serous adenocarcinoma of the uterus: criteria of morphological diagnosis and immunohistochemistry].
    Vasil'eva EV; Belianin VL
    Arkh Patol; 2005; 67(2):25-7. PubMed ID: 15938115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.
    Yemelyanova A; Ji H; Shih IeM; Wang TL; Wu LS; Ronnett BM
    Am J Surg Pathol; 2009 Oct; 33(10):1504-14. PubMed ID: 19623034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
    Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
    Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progesterone receptor expression and proliferative activity in uterine tumours of pet rabbits.
    Vinci A; Bacci B; Benazzi C; Caldin M; Sarli G
    J Comp Pathol; 2010 May; 142(4):323-7. PubMed ID: 20096851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical profile of endometrial adenocarcinoma: a study of 61 cases and review of the literature.
    Kounelis S; Kapranos N; Kouri E; Coppola D; Papadaki H; Jones MW
    Mod Pathol; 2000 Apr; 13(4):379-88. PubMed ID: 10786803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of nm23 in normal, hyperplastic and neoplastic endometrial tissues.
    Brustmann H; Naudé S
    Pathol Res Pract; 1999; 195(12):829-34. PubMed ID: 10631718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical characterization of endocervical papillary serous carcinoma.
    Nofech-Mozes S; Rasty G; Ismiil N; Covens A; Khalifa MA
    Int J Gynecol Cancer; 2006; 16 Suppl 1():286-92. PubMed ID: 16515605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Villoglandular papillary adenocarcinoma of the uterine cervix with immunohistochemical characteristics.
    Polat A; Düsmez D; Pata O; Aydin O; Egilmez R
    J Exp Clin Cancer Res; 2002 Sep; 21(3):425-7. PubMed ID: 12385589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of endometrial activity after radiation therapy for cervical carcinoma.
    Barnhill D; Heller P; Dames J; Hoskins W; Gallup D; Park R
    Obstet Gynecol; 1985 Dec; 66(6):805-8. PubMed ID: 2999661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervicovaginal cytology in uterine adenocarcinoma and adenosquamous carcinoma. Comparison of cytologic and histologic findings.
    Costa MJ; Kenny MB; Naib ZM
    Acta Cytol; 1991; 35(1):127-34. PubMed ID: 1994621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complex papillary hyperplasia of the endometrium: an uncommon case report with cytopathological features and diagnostic implications.
    Rekhi B; Menon S; Maheshwari A
    Diagn Cytopathol; 2015 Feb; 43(2):163-8. PubMed ID: 24825243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Morphological diagnosis of early forms of adenocarcinomas of the cervix].
    Novik VI; Chepik OF; Bokhman IaV
    Arkh Patol; 1983; 45(8):38-43. PubMed ID: 6639392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expressions of aromatase protein and sex hormone receptor in endometrial lesions].
    Ma XX; Zhang SL; Gao S; Lu JM; Dong F
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):395-8. PubMed ID: 16831363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of fascin and CK14 in different histological types of cancer and its differential diagnostic significance].
    Xue LY; Zou SM; Zheng S; Xie YQ; Wen P; Liu XY; Lin DM; Lü N
    Zhonghua Zhong Liu Za Zhi; 2010 Nov; 32(11):838-44. PubMed ID: 21223690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Villous glandular adenocarcinoma of the uterine cervix. A subtype with favourable prognosis?].
    Reed W; Abeler VM; Tropé CG
    Tidsskr Nor Laegeforen; 1993 Aug; 113(20):2569-71. PubMed ID: 8236177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MESONEPHRIC ADENOCARCINOMA OF ENDOCERVIX WITH LOBULAR MESONEPHRIC HYPERPLASIA: CASE REPORT.
    Puljiz M; Danolić D; Kostić L; Alvir I; Tomica D; Mamić I; Munivrana IV; Puljiz M; Vrdoljak DV; Balja MP
    Acta Clin Croat; 2016 Jun; 55(2):326-30. PubMed ID: 28394551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Claudin 1 differentiates endometrioid and serous papillary endometrial adenocarcinoma.
    Sobel G; Németh J; Kiss A; Lotz G; Szabó I; Udvarhelyi N; Schaff Z; Páska C
    Gynecol Oncol; 2006 Nov; 103(2):591-8. PubMed ID: 16797678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.